Aug 29 (Reuters) - SANDOZ INC:
* SANDOZ INC. VOLUNTARILY RECALLS LOSARTAN POTASSIUM AND EZETIMIBE IN PRESCRIPTION DRUG BOTTLES IN THE U.S. DUE TO FAILURE TO MEET CHILD-RESISTANT CLOSURE REQUIREMENTS
* SANDOZ INC - THERE ARE NO QUALITY OR SAFETY ISSUES WITH MEDICINES FOR THEIR INTENDED USE Source text for Eikon: Further company coverage: